Chloroquine-treatment failure in northern Ghana: Roles of pfcrt T76 and pfmdr1 Y86

Annals of Tropical Medicine and Parasitology

Volumn 99, Issue 8, 2005, Pages 723-732

  Mockenhaupt, F P ^a   Ehrhardt, S ^a,b   Eggelte, T A ^c   Agana Nsiire, P ^d   Stollberg, K ^a   Mathieu, A ^a   Markert, M ^a   Otchwemah, R N ^e   Bienzle, U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d Regional Health Directorate   (Ghana)

^e UNIVERSITY FOR DEVELOPMENT STUDIES   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; THREONINE; TYROSINE;

AGE; ARTICLE; CHILD; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG COST; FEMALE; GENE FUNCTION; GENE MUTATION; GENOTYPE; GHANA; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; MALNUTRITION; MONOTHERAPY; MULTIDRUG RESISTANCE; NUTRITIONAL STATUS; PARASITEMIA; PFCRT GENE; PFMDR1 GENE; PLASMODIUM FALCIPARUM; PROTOZOAL GENETICS; RISK FACTOR; TREATMENT FAILURE; TREATMENT OUTCOME;

ANIMALS; ANTIMALARIALS; ATP-BINDING CASSETTE TRANSPORTERS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; MALE; MALNUTRITION; MEMBRANE PROTEINS; MUTATION; PARASITEMIA; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; TREATMENT FAILURE;

PLASMODIUM FALCIPARUM;

EID: 28144443414     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/136485905X75395     Document Type: Article

References (37)

1. Abuaku, B. K., Koram, K. A. & Binka, F. N. (2004). Antimalarial drug use among caregivers in Ghana. African Health Sciences, 4, 171-177.
2. Babiker, H. A., Pringle, S. J., Abdel-Muhsin, A., Mackinnon, M., Hunt P. & Walliker, D. (2001). High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1. Journal of Infectious Diseases, 185, 405-407.
3. Brandts, C. H., Wernsdorfer, W. H. & Kremsner, P. G. (2000). Decreasing chloroquine resistance in Plasmodium falciparum isolates from Gabon. Transactions of the Royal Society of Tropical Medicine and Hygiene, 94, 554-556.
4. Djimdé, A., Doumbo, O. K., Cortese, J. F., Kayentao, K., Doumbo, S., Diourté, Y., Dicko, A., Su, X. Z., Nomura, T., Fidock, D. A., Wellems, T. E., Plowe, C. V. & Coulibaly, D. (2001a). A molecular marker for chloroquine-resistant falciparum malaria. New England Journal of Medicine, 344, 257-263.
5. Djimdé, A., Doumbo, O. K., Steketee, R. W. & Plowe, C. V. (2001b). Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet, 358, 890-891.
6. Dorsey, G., Kamya, M. R., Ndeezi, G., Babirye, J. N., Phares, C. R., Olson, J. E., Katabira, E. T. & Rosenthal, P. J. (2000). Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda. American Journal of Tropical Medicine and Hygiene, 62, 686-692.
7. Dorsey, G., Kamya, M. R., Singh, A. & Rosenthal, P. J. (2001). Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. Journal of Infectious Diseases, 183, 1417-1420.
8. Duraisingh, M. T. & Cowman, A. F. (2005). Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Tropica, 94, 181-190.
9. Ehrhardt, S., Mockenhaupt, F. P., Agana-Nsiire, P., Mathieu, A., Anemana, S. D., Stark, K., Otchwemah, R. N. & Bienzle, U. (2002). Efficacy of chloroquine in the treatment of uncomplicated, Plasmodium falciparum malaria in northern Ghana. Annals of Tropical Medicine and Parasitology, 96, 239-247.
10. Ehrhardt, S., Mockenhaupt, F. P., Eggelte, T. A., Agana-Nsiire, P., Stollberg, K., Anemana, S. D., Otchwemah, R. N. & Bienzle, U. (2003). Chloroquine blood concentrations and molecular markers of chloroquine-resistant Plasmodium falciparum in febrile children in northern Ghana. Transactions of the Royal Society of Tropical Medicine and Hygiene, 97, 697-701.
11. Fidock, D. A., Nomura, T., Talley, A. K., Cooper, R. A., Dzekunov, S. M., Ferdig, M. T., Ursos, L. M., Sidhu, A. B., Naude, B., Deitsch, K. W., Su, X. Z., Wootton, J. C., Roepe, P. D. & Wellems, T. E. (2000). Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Molecular Cell, 6, 861-871.
12. Flüeck, T. P., Jelinek, T., Kilian, A. H., Adagu, I. S., Kabagambe, G., Sonnenburg, F. & Warhurst, D. C. (2000). Correlation of in vivo-resistance to chloroquine and allelic polymorphisms in Plasmodium falciparum isolates from Uganda. Tropical Medicine and International Health, 5, 174-178.
13. Foster, S. D. (1991). Pricing, distribution, and use of antimalarial drugs. Bulletin of the World Health Organization, 69, 349-363.
14. Hamer, D. H., MacLeod, W. B., Addo-Yobo, E., Duggan, C. P., Estrella, B., Fawzi, W. W., Konde-Lule, J. K., Mwanakasale, V., Premji, Z. G., Sempertegui, F., Ssengooba, F. P., Yeboah-Antwi, K. & Simon, J. L. (2003). Age, temperature, and parasitaemia predict chloroquine treatment failure and anaemia in children with uncomplicated Plasmodium falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 97, 422-428.
15. Hess, F. I., Iannuzzi, A., Leafasia, J., Cowdrey, D., Nothdurft, H. D., von Sonnenburg, F., Löscher, T. & Rieckmann, K. H. (1996). Risk factors of chloroquine resistance in Plasmodium falciparum malaria. Acta Tropica, 61, 293-306.
16. Hess, F. I., Nukuro, E., Judson, L., Rodgers, J., Nothdurft, H. D. & Rieckmann, K. H. (1997). Anti-malarial drug resistance, malnutrition and socio-economic status. Tropical Medicine and International Health, 2, 721-728.
17. Jelinek, T., Aida, A. O., Peyerl-Hoffmann, G., Jordan, S., Mayor, A., Heuschkel C., El Valy, A. O., von Sonnenburg, F. & Christophel, E. M. (2002). Diagnostic value of molecular markers in chloroquine-resistant falciparum malaria in southern Mauritania. American Journal of Tropical Medicine and Hygiene, 67, 449-453.
18. Kublin, J. G., Cortese, J. F., Njunju, E. M., Mukadam, R. A., Wirima, J. J., Kazembe, P. N., Djimdé, A. A., Kouriba, B., Taylor, T. E. & Plowe, C. V. (2003). Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. Journal of Infectious Diseases, 187, 1870-1875.
19. Mockenhaupt, F. P., May, J., Bergqvist, Y., Ademowo, O. G., Olumese, P. E., Falusi, A. G., Grossterlinden, L., Meyer, C. G. & Bienzle, U (2000). Concentrations of chloroquine and malaria parasites in blood in Nigerian children. Antimicrobial Agents and Chemotherapy, 44, 835-839.
20. Niagia, S. (2004). Ghana battles drug-resistant malaria with artesunate. Lancet, 363, 1372.
21. Nocht, B. & Werner, H. (1910). Beobachtung über eine relative chininresistenz bei malaria aus Brasilien. Deutsche Medizinische Wochenschrift, 36, 1557-1561.
22. Ochong, E. O., van den Broek, I. V., Keus, K. & Nzila, A. (2003). Association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan. American Journal of Tropical Medicine and Hygiene, 69, 184-187.
23. Oduro, A. R., Anyorigiya, T., Hodgson, A., Ansah, P., Anto, F., Ansah, N. A., Atuguba, F., Mumuni, G. & Amankwa, J. (2005). A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana. Tropical Medicine and International Health, 10, 279-284.
24. Quashie, N. B., Akanmori, B. D., Goka, B. Q., Ofori-Adjei, D. & Kurtzhals, J. A. (2005). Pretreatment blood concentrations of chloroquine in patients with malaria infection: relation to response to treatment. Journal of Tropical Pediatrics, 51, 149-153.
25. Reed, M. B., Saliba, K. J., Caruana, S. R., Kirk, K. & Cowman, A. F. (2000). Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature, 403, 906-909.
26. Shretta, R., Omumbo, J., Rapuoda, B. & Snow, R. W. (2000). Using evidence to change antimalarial drug policy in Kenya. Tropical Medicine and International Health, 5, 755-764.
27. Snounou, G., Zhu, X., Siripoon, N., Jarra, W., Thaithong, S., Brown, K. N. & Viriyakosol, S. (1999). Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, 369-374.
28. Staedke, S. G., Sendagire, H., Lamola, S., Kamya, M. R., Dorsey, G. & Rosenthal, P. J. (2004). Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda. Tropical Medicine and International Health, 9, 624-629.
29. Thomas, S. M., Ndir, O., Dieng, T., Mboup, S., Wypij D., Maguire, J. H. & Wirth, D. F. (2002). In vitro chloroquine susceptibility and PCR analysis of pfcrt and pfmdr1 polymorphisms in Plasmodium falciparum isolates from Senegal. American Journal of Tropical Medicine and Hygiene, 66, 474-480.
30. Tinto, H., Ouedraogo, J. B., Erhart, A., van Overmeier, C., Dujardin, J. C., van Marck, E., Guiguemde, T. R. & d'Alessandro, U. (2003). Relationship between the Pfcrt T76 and the Pfmdr-1 Y86 mutations in Plasmodium falciparum and in vitro/ in vivo chloroquine resistance in Burkina Faso, West Africa. Infections, Genetics and Evolution, 4, 287-292.
31. Walker, O., Dawodu, A. H., Salako, L. A., Alvan, G. & Johnson, A. O. (1987). Single dose disposition of chloroquine in kwashiorkor and normal children - evidence for decreased absorption in kwashiorkor. British Journal of Clinical Pharmacology, 23, 467-472.
32. Wang, X., Mu, J., Li, G. Chen, P., Guo, X., Fu, L., Chen, L., Su, X. & Wellems, T. E. (2005). Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China. American Journal of Tropical Medicine and Hygiene, 72, 410-414.
33. White, N. J. (1998). Why is it that antimalarial drug treatments do not always work? Annals of Tropical Medicine and Parasitology, 92, 449-458.
34. Witte, A. M., Klever, H. J., Brabin, B. J., Eggelte, T. A., van der Kaay, H. J. & Alpers, M. P. (1990). Field evaluation of the use of an ELISA to detect chloroquine and its metabolites in blood, urine and breast-milk. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 521-525.
35. Wongsrichanalai, C., Pickard, A. L., Wernsdorfer, W. H. & Meshnick, S. R. (2002). Epidemiology of drug-resistant malaria. Lancet Infectious Diseases, 2, 209-218.
36. World Health Organization (1996). Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. Document WHO/MAL/ 96.1077. Geneva: WHO.
37. World Health Organization (2003). Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria. Document WHO/HTM/RBM/2003.50. Geneva: WHO.